RESUMO
Focal and segmental glomerulosclerosis (FSGS) is a common, non-specific renal lesion. Although it is often secondary to other disorders, including HIV infection, obesity, hypertension and diabetes, FSGS also appears as an isolated, idiopathic condition. FSGS is characterized by increased urinary protein excretion and decreasing kidney function. Often, renal insufficiency in affected patients progresses to end-stage renal failure, a highly morbid state requiring either dialysis therapy or kidney transplantation. Here we present evidence implicating mutations in the gene encoding alpha-actinin-4 (ACTN4; ref. 2), an actin-filament crosslinking protein, as the cause of disease in three families with an autosomal dominant form of FSGS. In vitro, mutant alpha-actinin-4 binds filamentous actin (F-actin) more strongly than does wild-type alpha-actinin-4. Regulation of the actin cytoskeleton of glomerular podocytes may be altered in this group of patients. Our results have implications for understanding the role of the cytoskeleton in the pathophysiology of kidney disease and may lead to a better understanding of the genetic basis of susceptibility to kidney damage.
Assuntos
Actinina/fisiologia , Cromossomos Humanos Par 19/genética , Glomerulosclerose Segmentar e Focal/genética , Proteínas dos Microfilamentos , Actinina/deficiência , Actinina/genética , Actinas/metabolismo , Sequência de Aminoácidos , Citoesqueleto/metabolismo , Citoesqueleto/ultraestrutura , Análise Mutacional de DNA , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Predisposição Genética para Doença , Humanos , Falência Renal Crônica/etiologia , Falência Renal Crônica/genética , Masculino , Dados de Sequência Molecular , Mutação , Linhagem , Alinhamento de Sequência , Homologia de Sequência de AminoácidosRESUMO
The feeding of sheep erythrocytes (SRBC) to mice leads to the production of two distinct T cell-derived suppressor factors by spleen cells. Each has been characterized for specificity, genetic restrictions, and cellular interactions. Fraction I has a 60,000-75,000 mol wt, is specific for antigen, and is suppressive of primary in vitro anti-SRBC responses at all times. It is not restricted by major histocompabitility complex (MHC)- or Igh-linked genes, but it fails to suppress spleen cells derived from any strain of mouse with a B10 background. It acts on an Lyt-2+ T cell to increase suppressive activity. An antiserum has been prepared against this factor that reacts with other, unrelated T cell suppressor factors. Fraction II has an approximately 30,000-40,000 mol wt, is specific for antigen, and has a dual effect on in vitro anti-SRBC responses. On day 3 of culture, it leads to augmentation of the response, whereas at day 5 it suppresses the response. It is not restricted by MHC genes, but it is restricted by Igh-linked genets. It acts by activating an Ly-1 t cell to both help and induce feedback suppression. These factors, and the antisera prepared against them, should allow more precise dissection of the molecular pathways by which immunoregulatory cells communicate with one another.
Assuntos
Formação de Anticorpos , Antígenos/administração & dosagem , Tolerância Imunológica , Baço/imunologia , Linfócitos T/imunologia , Administração Oral , Animais , Linfócitos B/imunologia , Comunicação Celular , Cadeias Pesadas de Imunoglobulinas/genética , Complexo Principal de Histocompatibilidade , CamundongosRESUMO
Seven transmembrane receptors and their associated heterotrimeric guanine nucleotide-binding proteins (G proteins) have been proposed to play a key role in modulating the activities of neurons and muscles. The physiological function of the Caenorhabditis elegans G protein Go has been genetically characterized. Mutations in the goa-1 gene, which encodes an alpha subunit of Go (G alpha o), cause behavioral defects similar to those observed in mutants that lack the neurotransmitter serotonin (5-HT), and goa-1 mutants are partially resistant to exogenous 5-HT. Mutant animals that lack G alpha o and transgenic animals that overexpress G alpha o [goa-1(xs) animals] have reciprocal defects in locomotion, feeding, and egg laying behaviors. In normal animals, all of these behaviors are regulated by 5-HT. These results demonstrate that the level of Go activity is a critical determinant of several C. elegans behaviors and suggest that Go mediates many of the behavioral effects of 5-HT.
Assuntos
Caenorhabditis elegans/fisiologia , Proteínas de Ligação ao GTP/fisiologia , Serotonina/fisiologia , Transdução de Sinais , Animais , Animais Geneticamente Modificados , Comportamento Animal/efeitos dos fármacos , Caenorhabditis elegans/efeitos dos fármacos , Caenorhabditis elegans/genética , Clonagem Molecular , Defecação , Comportamento Alimentar/efeitos dos fármacos , Feminino , Proteínas de Ligação ao GTP/genética , Genes de Helmintos , Movimento/efeitos dos fármacos , Contração Muscular , Neurônios/fisiologia , Octopamina/farmacologia , Oviposição/efeitos dos fármacos , Serotonina/farmacologiaRESUMO
We show that serotonin inhibits synaptic transmission at C. elegans neuromuscular junctions, and we describe a signaling pathway that mediates this effect. Release of acetylcholine from motor neurons was assayed by measuring the sensitivity of intact animals to the acetylcholinesterase inhibitor aldicarb. By this assay, exogenous serotonin inhibited acetylcholine release, whereas serotonin antagonists stimulated release. The effects of serotonin on synaptic transmission were mediated by GOA-1 (a Galpha0 subunit) and DGK-1 (a diacylglycerol [DAG] kinase), both of which act in the ventral cord motor neurons. Mutants lacking goa-1 G(alpha)0 accumulated abnormally high levels of the DAG-binding protein UNC-13 at motor neuron nerve terminals, suggesting that serotonin inhibits synaptic transmission by decreasing the abundance of UNC-13 at release sites.
Assuntos
Proteínas de Caenorhabditis elegans , Proteínas de Helminto/metabolismo , Proteínas Heterotriméricas de Ligação ao GTP/fisiologia , Serotonina/farmacologia , Transmissão Sináptica/efeitos dos fármacos , Acetilcolina/metabolismo , Aldicarb/farmacologia , Sequência de Aminoácidos , Animais , Caenorhabditis elegans , Proteínas de Transporte , Linhagem Celular , Inibidores da Colinesterase/farmacologia , Diacilglicerol Quinase/química , Diacilglicerol Quinase/genética , Diacilglicerol Quinase/metabolismo , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP , Proteínas Heterotriméricas de Ligação ao GTP/química , Proteínas Heterotriméricas de Ligação ao GTP/genética , Dados de Sequência Molecular , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/metabolismo , Mutação , Transdução de SinaisRESUMO
We show that neurotransmitter release at Caenorhabditis elegans neuromuscular junctions is facilitated by a presynaptic pathway composed of a Gqalpha (EGL-30), EGL-8 phospholipase Cbeta (PLCbeta), and the diacylglycerol- (DAG-) binding protein UNC-13. Activation of this pathway increased release of acetylcholine at neuromuscular junctions, whereas inactivation decreased release. Phorbol esters stimulated acetylcholine release, and this effect was blocked by a mutation that eliminates phorbol ester binding to UNC-13. Expression of a constitutively membrane-bound form of UNC-13 restored acetylcholine release to mutants lacking the egl-8 PLCbeta. Activation of this pathway with muscarinic agonists caused UNC-13 to accumulate in punctate structures in the ventral nerve cord. These results suggest that presynaptic DAG facilitates synaptic transmission and that part of this effect is mediated by UNC-13.
Assuntos
Proteínas de Caenorhabditis elegans , Proteínas de Ligação ao GTP/fisiologia , Isoenzimas/fisiologia , Transmissão Sináptica/fisiologia , Fosfolipases Tipo C/fisiologia , Acetilcolina/metabolismo , Sequência de Aminoácidos/genética , Animais , Caenorhabditis elegans , Proteínas de Transporte , Diglicerídeos/metabolismo , Proteínas de Helminto/metabolismo , Dados de Sequência Molecular , Neurônios Motores/fisiologia , Agonistas Muscarínicos/farmacologia , Junção Neuromuscular/metabolismo , Fosfolipase C beta , Acetato de Tetradecanoilforbol/farmacologia , Distribuição Tecidual/fisiologiaRESUMO
The C. elegans egl-36 gene encodes a Shaw-type potassium channel that regulates egg-laying behavior. Gain of function [egl-36(gf)] and dominant negative [egl-36(dn)] mutations in egl-36 cause reciprocal defects in egg laying. An egl-36::gfp reporter is expressed in the egg-laying muscles and in a few other tissues. Expression of an egl-36(gf) cDNA in the egg-laying muscles causes behavioral defects similar to those observed in egl-36(gf) mutants. Gain of function EGL-36 subunits form channels that are active at more negative potentials than wild-type channels. The egl-36(gf) alleles correspond to missense mutations in an amino terminal subunit assembly domain (E138K) and in the S6 transmembrane domain (P435S), neither of which were previously implicated in the voltage dependence of channel activation. Altogether, these results suggest that EGL-36 channels regulate the excitability of the egg-laying muscles.
Assuntos
Células COS/fisiologia , Músculos/fisiologia , Mutação/genética , Canais de Potássio de Abertura Dependente da Tensão da Membrana , Canais de Potássio/genética , Animais , Sequência de Bases , Proteínas de Caenorhabditis elegans , Dados de Sequência Molecular , Canais de Potássio ShawRESUMO
The proteins encoded by the oncogene v-src and its cellular counterpart c-src (designated generically here as pp60src) are tightly associated with both plasma membranes and intracellular membranes. This association is due in part to the amino-terminal myristylation of pp60src, but several lines of evidence suggest that amino-terminal portions of the protein itself are also involved. We now report that pp60src contains at least three domains which, in conjunction with myristylation, are capable of mediating attachment to membranes and determining subcellular localization. We identified these domains by fusing various portions of pp60src to pyruvate kinase, which is normally a cytoplasmic protein. Amino acids 1 to 14 of pp60src are sufficient to mediate both myristylation and the attachment of pyruvate kinase to cytoplasmic granules. In contrast, amino acids 38 to 111 mediate association with the plasma membrane and perinuclear membranes, whereas amino acids 204 to 259 mediate association primarily with perinuclear membranes. We conclude that pp60src contains independent domains that target the protein to distinctive subcellular locations and thus may facilitate diverse biological functions of the protein.
Assuntos
Membrana Celular/metabolismo , Proteínas de Membrana/genética , Proteína Oncogênica pp60(v-src)/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Animais , Células Cultivadas , Chlorocebus aethiops , Análise Mutacional de DNA , Imunofluorescência , Membranas Intracelulares/metabolismo , Ácido Mirístico , Ácidos Mirísticos/metabolismo , Membrana Nuclear/metabolismo , Proteína Oncogênica pp60(v-src)/ultraestrutura , Fosforilação , Ligação Proteica , Processamento de Proteína Pós-Traducional , Proteínas Proto-Oncogênicas/ultraestrutura , Proteínas Proto-Oncogênicas pp60(c-src) , Piruvato Quinase/metabolismo , Relação Estrutura-Atividade , TransfecçãoRESUMO
The transforming protein of Rous sarcoma virus, pp60v-src, is covalently coupled to myristic acid by an amide linkage to glycine 2. Myristylation promotes the association of pp60v-src with cellular membranes, and this subcellular location is essential for transforming activity. The findings presented here, in conjunction with the previous reports of others, imply that the seventh amino acid encoded by v-src might be important in the myristylation reaction. Replacement of lysine 7 by asparagine greatly reduced the myristylation, membrane association, and transforming activity of pp60v-src. In contrast, substitution of arginine at residue 7 had no effect on any of these properties of pp60v-src. Addition of amino acids 1 to 7 encoded by v-src was sufficient to cause myristylation of a src-pyruvate kinase fusion protein. We conclude that the recognition sequence for myristylation of pp60v-src comprises amino acids 1 to 7 and that lysine 7 is a critical component of this sequence.
Assuntos
Vírus do Sarcoma Aviário/genética , Ácidos Mirísticos/metabolismo , Proteínas Quinases/metabolismo , Proteínas dos Retroviridae/metabolismo , Acilação , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Células Cultivadas , Embrião de Galinha , Eletroforese em Gel de Poliacrilamida , Fibroblastos/microbiologia , Lisina/análise , Ácido Mirístico , Proteína Oncogênica pp60(v-src) , Proteínas Quinases/análise , Proteínas dos Retroviridae/análise , Proteínas dos Retroviridae/imunologiaRESUMO
The simple anatomy, behavior, and genetics of the nematode Caenorhabditis elegans make it an attractive organism for studying sensory circuits and their functions in vivo. Recent advances in our understanding of C. elegans sensory signaling stem from work on topographic maps, chemosensory receptors, modality coding, and the integration of antagonistic sensory inputs.
Assuntos
Caenorhabditis elegans/fisiologia , Sensação/fisiologia , Transdução de Sinais , Animais , Células Quimiorreceptoras/fisiologia , Células Receptoras Sensoriais/fisiologiaRESUMO
The elevation of plasma ghrelin associated with weight loss has been taken as evidence of a role for ghrelin in the adaptive response to body weight change. However, there has been no clear experimental evidence that circulating ghrelin is suppressed by weight gain. We investigate this issue using a model of involuntary (intra-gastric gavage) overfeeding-induced obesity. Rats were first maintained at normal body weight with 4 daily tube-feedings of liquid diet (2.11 kcal/ml), each delivered at a volume of 9 ml. Gavage volume was then increased to 13 ml/feeding for 2 weeks, during which rats gained 25% of their initial body weight. Fasting plasma ghrelin levels and the response to 9- and 13-ml intra-gastric load sizes were measured during the weight-stable and overfed conditions. We found that: 1) weight gain decreased circulating ghrelin levels; 2) this response could not be attributed to additional food in the gastrointestinal tract; 3) the ghrelin response to nutrient loads was diminished in the obese vs normal-weight conditions. Having discounted diet composition and differences in gastric contents at the time of blood sampling, the decrease in ghrelin levels with overfeeding can be unambiguously attributed to physiological correlates of weight gain.
Assuntos
Hiperfagia/sangue , Hiperfagia/fisiopatologia , Hormônios Peptídicos/sangue , Aumento de Peso/fisiologia , Tecido Adiposo/fisiopatologia , Animais , Peso Corporal/fisiologia , Metabolismo Energético/fisiologia , Grelina , Masculino , Obesidade/sangue , Obesidade/etiologia , Obesidade/fisiopatologia , Ratos , Ratos Sprague-DawleyRESUMO
Neuroactive peptides are packaged as proproteins into dense core vesicles or secretory granules, where they are cleaved at dibasic residues by copackaged proprotein convertases. We show here that the Caenorhabditis elegans egl-3 gene encodes a protein that is 57% identical to mouse proprotein convertase type 2 (PC2), and we provide evidence that this convertase regulates mechanosensory responses. Nose touch sensitivity (mediated by ASH sensory neurons) is defective in mutants lacking GLR-1 glutamate receptors (GluRs); however, mutations eliminating the egl-3 PC2 restored nose touch sensitivity to glr-1 GluR mutants. By contrast, body touch sensitivity (mediated by the touch cells) is greatly diminished in egl-3 PC2 mutants. Taken together, these results suggest that egl-3 PC2-processed peptides normally regulate the responsiveness of C. elegans to mechanical stimuli.
Assuntos
Comportamento Animal/fisiologia , Proteínas de Caenorhabditis elegans , Caenorhabditis elegans/fisiologia , Mecanorreceptores/fisiologia , Subtilisinas/genética , Animais , Mapeamento Cromossômico , Clonagem Molecular , Proteínas de Helminto/genética , Proteínas de Helminto/metabolismo , Locomoção/fisiologia , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Neurônios/fisiologia , Especificidade de Órgãos , Oviposição/fisiologia , Estimulação Física , Pró-Proteína Convertase 2 , Receptores de AMPA , Receptores de Glutamato/deficiência , Receptores de Glutamato/fisiologia , Subtilisinas/metabolismo , Sinapses/fisiologia , Tato/fisiologiaRESUMO
BACKGROUND: Adenoviral constructs have been used for studies of injury-induced vascular hyperplasia in immunologically naive laboratory animals, but their usefulness for intra-arterial gene therapy may be limited by the prevalence of preexisting immunity to adenovirus in the patient population. Here, we explored the efficacy of adenovirus-mediated transfer of Fas ligand, a cytotoxic gene with immunomodulatory properties, in inhibiting injury-induced vascular lesion formation in both naive and immunologically primed animals. METHODS AND RESULTS: Lesion formation was evaluated in balloon-injured carotid arteries of naive and adenovirus-immunized rats that were infected with adenoviral constructs expressing Fas ligand (Ad-FasL), the cyclin-dependent kinase inhibitor p21 (Ad-p21), or beta-galactosidase (Ad-betagal). In naive rats, Ad-FasL induced apoptosis in medial vascular smooth muscle cells and inhibited intimal hyperplasia by 60% relative to Ad-betagal-treated vessels (P<0.05), whereas the cytostatic agent Ad-p21 decreased lesion size by 58% (P<0.05). In animals preimmunized with an adenoviral vector containing no transgene, Ad-FasL significantly inhibited neointima formation (73% reduction, P<0.05), but Ad-p21 failed to inhibit neointima formation relative to controls. Immunologically primed rats displayed robust T-cell infiltration in Ad-p21- and Ad-betagal-treated vessels, but T-cell infiltration was markedly attenuated in Ad-FasL-treated vessels. CONCLUSIONS: Our data demonstrate that adenovirus-mediated Fas ligand delivery can inhibit intimal hyperplasia in both immunologically primed and naive animals, whereas the efficacy of an adenovirus-mediated p21 delivery is limited to immunologically naive animals. This study documents, for the first time, the therapeutic efficacy of intravascular adenoviral gene transfer in animals with preexisting immunity to adenovirus.
Assuntos
Adenoviridae/imunologia , Doenças das Artérias Carótidas/prevenção & controle , Cateterismo , Técnicas de Transferência de Genes , Imunização , Glicoproteínas de Membrana/administração & dosagem , Adenoviridae/genética , Animais , Artérias Carótidas/efeitos dos fármacos , Artérias Carótidas/patologia , Doenças das Artérias Carótidas/patologia , Proteína Ligante Fas , Hiperplasia/prevenção & controle , Masculino , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/farmacologia , Ratos , Ratos Sprague-Dawley , Túnica Íntima/patologia , Vasculite/prevenção & controleRESUMO
All admissions to the Singer Mental Health Center, Rockford, Ill, with a diagnosis of alcoholism in a one-year period (N = 466) were randomly assigned to one of two inpatient programs. One program, "intensive incare," had a high staff-patient ratio with the operating assumption that intensive staff-patient interaction is significant in patient outcome. The other, "peer-oriented incare," was of low staff density with the assumption that patient-patient interaction is critical in rehabilitation. In addition, the patients resided in communities with outpatient services classified as either "network" (an organized set of community services) or "no-network" (no special funding or deliberate outreach effort). Thus, each patient could be treated in one of four systems of care. Data on treatment outcomes were collected via semistructured interviews at 3, 6, 12, and 18 months after admission. The "peer-oriented incare" system showed superiority to the "intensive incare" treatment approach in improved drinking behavior. There were no other significant differences among the four systems on the outcome criteria for alcoholic patients. Along with other recent studies, these findings have implications for policy planning, particularly with today's emphasis on cost effectiveness.
Assuntos
Alcoolismo/terapia , Serviços Comunitários de Saúde Mental , Adulto , Consumo de Bebidas Alcoólicas , Alcoolismo/reabilitação , Assistência Ambulatorial , Emprego , Feminino , Seguimentos , Humanos , Masculino , Avaliação de Processos e Resultados em Cuidados de Saúde , Admissão do Paciente , Equipe de Assistência ao Paciente , Ajustamento Social , Fatores de TempoRESUMO
Animal studies have suggested that the clinical usefulness of recombinant adenoviruses (Ad) as vectors for therapeutic gene delivery may be limited by their immunogenicity. Neutralizing antibodies elicited by capsid proteins reduce the efficiency of vector readministration whereas cytotoxic T lymphocytes (CTLs) directed against viral proteins and/or immunogenic transgene products expressed by transfected cells have the potential to limit persistence of expression. In this study, transient administration of the novel immunosuppressant deoxyspergualin (DSG) was found to inhibit the development of both humoral and cell-mediated immune responses against Ad vector delivered intranasally. DSG treatment of primed mice previously exposed to wild-type Ad impaired the development of antibodies in response to a secondary and even tertiary challenge with Ad vector. As a result, improved gene transfer was obtained upon subsequent administration of a beta-galactosidase (beta-Gal)-encoding Ad vector. Short-term administration of DSG also depressed the activation of CD4+ and CD8+ T lymphocytes as assessed by measurement of antigen-specific proliferation and CTL activity, respectively. The marked suppression of CTL activity against Ad vector in DSG-treated mice correlated with improved persistence of transgene expression in the lung.
Assuntos
Adenoviridae/genética , Guanidinas/farmacologia , Imunossupressores/farmacologia , Pulmão/virologia , Transgenes , Adenoviridae/efeitos dos fármacos , Adenoviridae/imunologia , Animais , Regulação Neoplásica da Expressão Gênica , Técnicas de Transferência de Genes , Vetores Genéticos/genética , Vetores Genéticos/imunologia , Imunidade Celular , Pulmão/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BLRESUMO
Effective gene transfer to the airway epithelial cells of individuals with cystic fibrosis (CF) requires gene therapy vectors to effectively penetrate the mucous lining of the airways of these patients. In this study, we examined the effects of the aqueous sol fraction of sputum recovered from CF patients (CF sol) on adenovirus (Ad)-mediated gene transfer to cultured epithelial cells. Sputum collected from patients with CF was separated into aqueous sol and gel fractions by ultracentrifugation and the sol fraction from different individuals was pooled. To determine if CF sol affects Ad-mediated transfection, Fisher rat thyroid (FRT) epithelial cells or normal human bronchial epithelial (NHBE) cells were infected with an Ad encoding beta-galactosidase (Ad2/betagal-2) in the presence or absence of the pooled CF sol. Transfection efficiency was determined by measuring beta-Gal activity. CF sol significantly inhibited Ad2-mediated gene transfer in a dose-dependent manner when the vector was incubated with CF sol prior to exposure to the cells. In contrast, preincubation of the cells with the sol was without effect. The inhibition of Ad-mediated gene transfer by CF sol was not related to its low pH, was abrogated by preadsorption with an Ad2 serotype vector, and was neutralized by heat treatment, but was not affected by treatment with protease inhibitors. Analysis of CF sol fractions from seven different individuals with CF showed inhibition of Ad-mediated gene transfer in four of the seven samples tested and, further, the inhibitory effect was correlated with the presence of Ad-specific antibodies. We conclude that preexisting adenovirus-specific antibodies present in some of the patient samples were the predominant factor inhibiting Ad-mediated gene transfer.
Assuntos
Adenoviridae/genética , Fibrose Cística/metabolismo , Células Epiteliais/metabolismo , Técnicas de Transferência de Genes , Terapia Genética/métodos , Escarro/metabolismo , Animais , Western Blotting , Brônquios/metabolismo , Catepsina G , Catepsinas/farmacologia , Células Cultivadas , Relação Dose-Resposta a Droga , Humanos , Concentração de Íons de Hidrogênio , Elastase de Leucócito/farmacologia , Inibidores de Proteases/farmacologia , Ratos , Serina Endopeptidases , Temperatura , Transdução Genética , Transfecção , Células Tumorais Cultivadas , Ultracentrifugação , beta-Galactosidase/genéticaRESUMO
In this study, the safety and efficacy of aerosol delivery to non-human primates of an adenoviral vector encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR) were evaluated. The technique of concurrent flow spirometry was used to determine the deposited dose of Ad2/CFTR-2, which ranged from 3 to 8 x 10(10) I.U. Transgene DNA was detected by the polymerase chain reaction (PCR) in lung tissue from all treated animals, and human CFTR mRNA was detected on days 3, 7, and 21 post-exposure. The treatment was well tolerated, with no evidence of respiratory distress. Histologic changes in the lungs from Ad2/CFTR-2-treated animals were mild and, overall, indistinguishable from animals exposed to aerosolized vehicle. One vector-treated animal demonstrated an increase in lavage lymphocyte numbers 3 days after treatment and another had an abnormal chest radiograph 14 days after treatment. A third vector-treated animal had histologic evidence of a bronchointerstitial pneumonia 7 days after aerosol treatment that resolved by day 21. This study demonstrated that Ad2/CFTR-2 can effectively be delivered to the lungs of nonhuman primates and result in minimal adverse effects.
Assuntos
Adenovírus Humanos/genética , Regulador de Condutância Transmembrana em Fibrose Cística/administração & dosagem , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Técnicas de Transferência de Genes , Terapia Genética/métodos , Vetores Genéticos/administração & dosagem , Pulmão , Adenovírus Humanos/imunologia , Adulto , Aerossóis , Animais , Expressão Gênica , Vetores Genéticos/genética , Humanos , Pulmão/diagnóstico por imagem , Pulmão/patologia , Macaca mulatta/fisiologia , Reação em Cadeia da Polimerase , RNA Mensageiro/análise , Radiografia , TransgenesRESUMO
One potential limitation of adenovirus (Ad)-based vectors for the gene therapy of cystic fibrosis (CF) and other genetic diseases is the transience of expression observed in most in vivo systems. In this study, the influence of various factors on persistence of transgene expression in the lung was investigated. In the absence of immune pressure, such as in the nude mouse, the genomic structure of the vector was found to be predominant in determining the persistence of expression; Ad vector constructs with an E1-E3+E4ORF6+ backbone encoding beta-galactosidase (beta-Gal) or the cystic fibrosis transmembrane conductance regulator (CFTR) produced declining levels of expression while an Ad/CMV beta Gal vector with an E1-E3+E4+ backbone gave rise to sustained, long-term reporter gene expression. The ability of the latter vector to persist was in turn limited in part by the presence of cytotoxic T lymphocytes (CTLs). Adoptive transfer experiments indicated that CTLs directed against either viral proteins or the beta-Gal reporter gene product were able to reduce expression in nude C57BL/6 mice stably expressing beta-Gal from the E4+ vector. Finally, the specificity and strength of the CTL response elicited by Ad vector was found to vary considerably depending on mouse strain haplotype. These results indicate that persistence of transgene expression in a given system is determined by the interplay between several factors including genomic structure of the vector, host background, and immune response.
Assuntos
Adenoviridae/genética , Regulação da Expressão Gênica/genética , Técnicas de Transferência de Genes , Animais , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , DNA Recombinante , DNA Viral/genética , DNA Viral/metabolismo , Genes Reporter/genética , Terapia Genética , Vetores Genéticos/genética , Vetores Genéticos/metabolismo , Haplótipos/genética , Pulmão/metabolismo , Camundongos , Camundongos Endogâmicos , Camundongos Nus , Linfócitos T Citotóxicos/imunologia , Linfócitos T Citotóxicos/metabolismo , Proteínas Virais/imunologia , Proteínas Virais/metabolismo , beta-Galactosidase/genética , beta-Galactosidase/metabolismoRESUMO
Recombinant adenovirus (Ad) vectors are being considered for in vivo delivery of various therapeutic genes. One limiting factor in the development of Ad-based gene therapy is the low efficiency of gene transfer to target tissues such as vascular endothelium, smooth muscle, and airway epithelium. Complexing Ad vector with various polycations has been shown to enhance transduction of cell lines otherwise resistant to Ad infection in vitro. On the basis of this observation, the activity of Ad/polycation complexes was tested in vivo in the mouse lung. The results indicated that several polycations were capable of enhancing transduction of mouse respiratory epithelium, leading to a 1-2 log increase in levels of transgene expression. Poly-L-lysine (PLL) and DEAE-dextran were examined further and were found to increase Ad-mediated gene transfer without any additional toxicity as assessed histologically or through the measurement of inflammatory cytokines in bronchoalveolar lavages. The two polycations also failed to affect the humoral response against Ad vector and were themselves nonimmunogenic under conditions leading to enhanced gene transfer. Moreover, the ability to use reduced doses of vector complexed with polycations resulted in lower levels of Ad-specific antibodies and, thereby, improved readministration of vector. These results suggest that complexing Ad vectors with polycations has the potential to improve the therapeutic index by increasing transgene expression while reducing unwanted responses associated with high doses of vector.
Assuntos
Adenoviridae/genética , Técnicas de Transferência de Genes , Vetores Genéticos/genética , Pulmão , Polímeros/farmacologia , Animais , DEAE-Dextrano/imunologia , DEAE-Dextrano/farmacologia , DEAE-Dextrano/uso terapêutico , Vetores Genéticos/imunologia , Vetores Genéticos/uso terapêutico , Pulmão/enzimologia , Lisina/imunologia , Lisina/farmacologia , Lisina/uso terapêutico , Camundongos , Camundongos Endogâmicos BALB C , Polímeros/uso terapêutico , Linfócitos T Citotóxicos/imunologia , beta-Galactosidase/genética , beta-Galactosidase/metabolismoRESUMO
Studies have indicated that although abundant levels of transgene expression could be achieved in the lungs of mice instilled with cationic lipid:pDNA complexes, the efficiency of gene transfer is low. As a consequence, a relatively large amount of the complex will need to be administered to the human lungs to achieve therapeutic efficacy for indications such as cystic fibrosis. Because all cationic lipids exhibit some level of cytotoxicity in vitro, we assessed the safety profile of one such cationic lipid, GL-67, following administration into the lungs of BALB/c mice. Dose-dependent pulmonary inflammation was observed that was characterized by infiltrates of neutrophils, and, to a lesser extent, macrophages and lymphocytes. The lesions in the lung were multifocal in nature and were manifested primarily at the junction of the terminal bronchioles and alveolar ducts. The degree of inflammation abated with time and there were no apparent permanent fibrotic lesions, even in animals that were treated at the highest doses. Analysis of the individual components of the complex revealed that the pulmonary inflammation was primarily cationic lipid-mediated with a minor contribution from the neutral co-lipid DOPE. Associated with the lesions in the lungs were elevated levels of the pro-inflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma) that peaked at days 1-2 post-instillation but resolved to normal limits by day 14. Total cell counts, primarily of neutrophils, were also significantly elevated in the bronchoalveolar lavage fluids of GL-67:pDNA-treated mice between days 1 and 3 but returned to normal limits by day 14. No specific immune responses were detected against the cationic lipid or plasmid DNA in mice that had been either instilled or immunized with the individual components or complex, nor was there any evidence of complement activation. These studies indicate that a significant improvement in the potency of cationic lipid:pDNA formulations is desirable to minimize the toxicity associated with cationic lipids.
Assuntos
Cátions/farmacocinética , DNA/farmacocinética , Técnicas de Transferência de Genes/efeitos adversos , Terapia Genética/métodos , Lipídeos/farmacocinética , Pulmão/efeitos dos fármacos , Administração Intranasal , Animais , Formação de Anticorpos , Líquido da Lavagem Broncoalveolar/química , Líquido da Lavagem Broncoalveolar/citologia , Cátions/imunologia , Cátions/toxicidade , Ativação do Complemento , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Citocinas/análise , DNA/administração & dosagem , DNA/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Humanos , Lipídeos/imunologia , Lipídeos/toxicidade , Pulmão/citologia , Pulmão/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Fosfatidiletanolaminas , Plasmídeos/genética , Alvéolos Pulmonares/efeitos dos fármacos , Alvéolos Pulmonares/metabolismo , Fatores de Tempo , TransgenesRESUMO
In ingestive taste reactivity analysis, the rhythmic oral motor responses observed during intraoral infusion of fluids normally ingested by rats are categorized and counted. These rhythmic movements can be likened to spout-licking in several respects. Both are emitted in the same frequency range (5-8 Hz), organized in a burst/pause pattern, and serve the function of intraoral transport of fluid into position for swallowing. The parallel suggests that a temporal pattern analysis, based on the spout-licking literature, can be fruitfully applied to the rhythmic movements that attend intraoral infusion. We provide a demonstration of such an analysis using an electromyographic (EMG) recording-based method for automated event detection. Eight rats received a 37.5% glucose solution (1.0 ml/min) in a series of 120 s infusion trials (45 s intertrial intervals) that was extended until the fluid was rejected. Movement counts declined 19.1% from the first to the last complete trial. Parameters derived from the pattern analysis (number of bursts, mean burst duration, pause durations, coefficient of variation for the distribution of within-burst intermovement intervals) were affected to a greater extent. The results indicate the potential value of temporal pattern analysis for various applications of the taste reactivity paradigm.